High publishing costs and a crumbling peer review infrastructure are symptoms of deeper structural issues in research.

The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...

Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...

An experimental Pfizer sickle cell treatment failed to meet the main goal in a late-stage trial for patients aged 16 and ...

Kennedy would be less hazardous if he decided to do cardiac surgery. Then he would kill people only one at a time,” writes ...

The Texas measles outbreak that sickened 762 people since late January is over, state health officials said Monday.

Hello, hello — glad you’re here! Some housekeeping: Health Care Inc. is off until Sept. 8. I’m also going on parental leave ...

In a highly unusual move, a small biotech has disclosed a rejection letter from the FDA in hopes of rallying support for ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

Morning. Today, we examine the plush pay packages of health care’s top CEOs in 2024. Also, we discuss Stealth BioTherapeutics’ efforts to rally support behind its Barth syndrome drug, and hear more ...

Last November, in the days following Donald Trump’s election, leaders at the National Institutes of Health began discussing ...

With U.S. funding for science at risk, a longtime advocate sees ‘light at the end of the tunnel’ in Washington.